+39 02 610346.1 - info@newron.com

Latest press releases

  • 16Sep
    Newron Pharmaceuticals reports half-year results 2014


  • 29Jul
    Refusal to File letter received from US FDA for safinamide, based on organization and navigation problems


  • 11Jul
    Newron shares to be included in the SXI Life Sciences® and the SXI Bio+Medtech® indices


  • 8Jul
    Newron establishes US operations


  • 29May
    Safinamide New Drug Application (NDA) submitted to the US Food and Drug Administration (FDA)


  • 12May
    Safinamide Update

View All

Newron share price


  • 24Nov
    German Equity Forum

    November 24-26, 2014 - Frankfurt-am-Main - Germany

  • 5Nov
    Vontobel Healthcare Tour

    November 5, 2014 - Zürich, Switzerland

  • 7Oct
    Bio Investor Forum

    October 7-8, 2014 - Palace Hotel, San Francisco, CA - USA

View Event Calendar